Alliance for Pandemic Preparedness

February 19, 2021

COVID-19 Prevalence and Mortality Among Schizophrenia Patients: A Large-Scale Retrospective Cohort Study

Category:

Topic:

Keywords (Tags): ,

A large-scale retrospective cohort study in Israel found that individuals with schizophrenia (n = 25,539) were twice as likely to be hospitalized for COVID-19 (OR = 2.2), even after controlling for sociodemographic and clinical risk factors (OR = 1.9). They were also three times more likely to experience COVID-19 mortality (OR = 3.3) compared to people without schizophrenia. Exploratory analyses of the characteristics of individuals who were hospitalized or deceased indicated that hospitalized patients with schizophrenia were predominantly males at a higher mean age and with a higher prevalence of smoking, obesity, diabetes, and COPD.

Tzur Bitan et al. (Feb 2021). COVID-19 Prevalence and Mortality Among Schizophrenia Patients: A Large-Scale Retrospective Cohort Study. Schizophrenia Bulletin. https://pubmed.ncbi.nlm.nih.gov/33604657/